Literature DB >> 6792318

Responder T cells depleted of alloreactive cells react to antigen presented on allogeneic macrophages from nonresponder strains.

N Ishii, C N Baxevanis, Z A Nagy, J Klein.   

Abstract

T cells from strains responder to the antigen poly(Glu40 Ala60) (GA) were depleted of alloreactive cells by bromo-deoxyuridine and light treatment, and were subsequently primed in vitro in GA presented by allogeneic macrophages from nonresponder strains. Antigen-specific secondary proliferative responses restricted by allogeneic Ia molecules of the macrophages were obtained in all strain combinations tested. These data indicate that Ir gene-controlled nonresponsiveness cannot be the result of a failure of antigen presentation.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6792318      PMCID: PMC2186446          DOI: 10.1084/jem.154.3.978

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  14 in total

Review 1.  Fine specificity analysis with monoclonal antibodies of antigens controlled by the major histocompatibility complex and by the Qa/TL region in mice.

Authors:  H Lemke; G J Hämmerling; U Hämmerling
Journal:  Immunol Rev       Date:  1979       Impact factor: 12.988

2.  Major histocompatibility complex-linked immune-responsiveness is acquired by lymphocytes of low-responder mice differentiating in thymus of high-responder mice.

Authors:  H von Boehmer; W Haas; N K Jerne
Journal:  Proc Natl Acad Sci U S A       Date:  1978-05       Impact factor: 11.205

3.  Nature of T cell-macrophage interaction in helper cell induction in vitro. III. Responsiveness of T cells differentiating in irradiation or allophenic chimeras depends on the genotype of the host.

Authors:  P Erb; P Vogt; T Matsunaga; A Rosenthal; M Feldmann
Journal:  J Immunol       Date:  1980-06       Impact factor: 5.422

Review 4.  A hypothesis to relate the specificity of T lymphocytes and the activity of I region-specific Ir genes in macrophages and B lymphocytes.

Authors:  B Benacerraf
Journal:  J Immunol       Date:  1978-06       Impact factor: 5.422

5.  Genetic control of T-cell proliferative responses to poly(glu40ala60) and poly(glu51lys34tyr15): subregion-specific inhibition of the responses with monoclonal Ia antibodies.

Authors:  C N Baxevanis; D Wernet; Z A Nagy; P H Maurer; J Klein
Journal:  Immunogenetics       Date:  1980       Impact factor: 2.846

6.  Nature of the antigenic complex recognized by T lymphocytes: specific sensitization by antigens associated with allogeneic macrophages.

Authors:  D W Thomas; E M Shevach
Journal:  Proc Natl Acad Sci U S A       Date:  1977-05       Impact factor: 11.205

7.  The generation of killer cells to trinitrophenyl-modified allogeneic targets by lymphocyte populations negatively selected to strong alloantigens.

Authors:  D B Wilson; K F Lindahl; D H Wilson; J Sprent
Journal:  J Exp Med       Date:  1977-08-01       Impact factor: 14.307

8.  The role of H-2 linked genes in helper T-cell function. IV. Importance of T-cell genotype and host environment in I-region and Ir gene expression.

Authors:  J W Kappler; P Marrack
Journal:  J Exp Med       Date:  1978-12-01       Impact factor: 14.307

9.  T cells specific for hapten-modified self are precommitted for self major histocompatibility complex antigens before encounter with the hapten.

Authors:  C A Janeway; P D Murphy; J Kemp; H Wigzell
Journal:  J Exp Med       Date:  1978-04-01       Impact factor: 14.307

10.  Gene complementation. Neither Ir-GLphi gene need be present in the proliferative T cell to generate an immune response to Poly(Glu55Lys36Phe9)n.

Authors:  D L Longo; R H Schwartz
Journal:  J Exp Med       Date:  1980-06-01       Impact factor: 14.307

View more
  27 in total

1.  Preferential restriction of minor alloantigen-specific suppressor T cells to I-E rather than I-A molecules.

Authors:  N K Nanda
Journal:  Immunology       Date:  1989-10       Impact factor: 7.397

2.  Interaction between a "processed" ovalbumin peptide and Ia molecules.

Authors:  S Buus; S Colon; C Smith; J H Freed; C Miles; H M Grey
Journal:  Proc Natl Acad Sci U S A       Date:  1986-06       Impact factor: 11.205

3.  Human allospecific TLCs generated against HLA antigens associated with DR1 through DRw8. II. Population analyses and blocking studies with monoclonal antibodies.

Authors:  S Rosen-Bronson; A H Johnson; R J Hartzman; D D Eckels
Journal:  Immunogenetics       Date:  1986       Impact factor: 2.846

4.  Age-dependent appearance of non-major histocompatibility complex-restricted helper T cells.

Authors:  C Russo; E P Cherniack; A Wali; M E Weksler
Journal:  Proc Natl Acad Sci U S A       Date:  1993-12-15       Impact factor: 11.205

5.  Structural analysis of insulin determinants seen by T cells directed by H-2 genes.

Authors:  J Talmon; G Ranghino; A Yonath; I R Cohen
Journal:  Immunogenetics       Date:  1983       Impact factor: 2.846

Review 6.  Mononuclear phagocytes: phenotype and function.

Authors:  D L Thiele; P E Lipsky
Journal:  Surv Immunol Res       Date:  1984

7.  Molecular events in the processing of avidin by antigen-presenting cells (APC). III. Activation of T-lymphocyte lines and H-2 restriction are mediated by processed avidin associated with I-region gene products.

Authors:  A Friedman; R Zerubavel; C Gitler; I R Cohen
Journal:  Immunogenetics       Date:  1983       Impact factor: 2.846

8.  Selection of H-2 molecules for the context of antigen recognition by T lymphocytes.

Authors:  N Ishii; C N Baxevanis; Z A Nagy; J Klein
Journal:  Immunogenetics       Date:  1981       Impact factor: 2.846

9.  Specific allogeneic help by T lymphocytes from patients with systemic lupus erythematosus.

Authors:  M K Hari Kumar; R A Knight; M L Snaith
Journal:  Clin Exp Immunol       Date:  1984-10       Impact factor: 4.330

10.  Mechanisms of genetic control of immune responses. I. Evidence for distinct multi-step helper T-cell pathways in cellular and humoral responses to GAT.

Authors:  S D Miller; R W Melvold; C Waltenbaugh
Journal:  Immunogenetics       Date:  1984       Impact factor: 2.846

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.